IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice

International Immunology

Volumn 22, Issue 4, 2010, Pages 245-257

  Voronov, Elena ^a   Dotan, Shahar ^a   Gayvoronsky, Lubov ^a   White, Rosalyn M ^a   Cohen, Idan ^a   Krelin, Yakov ^a   Benchetrit, Fabrice ^a   Elkabets, Moshe ^a   Huszar, Monika ^b   El On, Joseph ^a   Apte, Ron N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Interleukin 1 receptor antagonist; Interleukin 1 ; Interleukin 1 ; Leishmaniasis; Pro inflammatory cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; INFECTION RESISTANCE; INFLAMMATION; LEISHMANIA MAJOR; LEISHMANIASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SUPPRESSOR CELL;

ANIMALS; DISEASE SUSCEPTIBILITY; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT;

EID: 77954067038     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq006     Document Type: Article

References (63)

1. Locksley, R. M., Pingel, S., Lacy, D., Wakil, A. E., Bix, M. and Fowell, D. J. 1999. Susceptibility to infectious diseases: Leishmania as a paradigm. J. Infect. Dis. 179(Suppl. 2):S305.
2. Reiner, N. E. 2005. Targeting cell regulation promotes pathogen survival in macrophages. Clin. Immunol. 114:213.
3. Louis, J., Gumy, A., Voigt, H., Rocken, M. and Launois, P. 2002. Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation. Eur. J. Dermatol. 12:316.
4. Reiner, S. L. and Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
5. Sacks, D. and Noben-Trauth, N. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845.
6. Apte, R. N. and Voronov, E. 2008. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol. Rev. 222:222.
7. Auron, P. E. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221.
8. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095.
9. Mantovani, A., Muzio, M., Ghezzi, P., Colotta, C. and Introna, M. 1998. Regulation of inhibitory pathways of the interleukin-1 system. Ann. N. Y. Acad. Sci. 840:338.
10. Petrilli, V., Dostert, C., Muruve, D. A. and Tschopp, J. 2007. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19:615.
11. Stylianou, E. and Saklatvala, J. 1998. Interleukin-1. Int. J. Biochem. Cell Biol. 30:1075.
12. Kostka, S. L., Knop, J., Konur, A., Udey, M. C. and von Stebut, E. 2006. Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections. J. Invest. Dermatol. 126:1582.
13. Von Stebut, E., Ehrchen, J. M., Belkaid, Y. et al. 2003. Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J. Exp. Med. 198:191.
14. Iwakura, Y. 2002. [The role of IL-1 in the development of autoimmunity]. Tanpakushitsu Kakusan Koso 47:2349.
15. Iwakura, Y. 2005. [Interleukin-1 in pathogenesis of rheumatoid arthritis]. Nippon Rinsho 63(Suppl. 1):153.
16. Apte, R. N., Dotan, S., Elkabets, M. et al. 2006. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumorhost interactions. Cancer Metastasis Rev. 25:387.
17. Apte, R. N., Krelin, Y., Song, X. et al. 2006. Effects of microenvironmentand malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur. J. Cancer 42:751.
18. Krelin, Y., Voronov, E., Dotan, S. et al. 2007. Interleukin1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67:1062.
19. Song, X., Krelin, Y., Dvorkin, T. et al. 2005. CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells. J. Immunol. 175:8200.
20. IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur
21. Horai, R., Asano, M., Sudo, K. et al. 1998. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463.
22. Bersudsky, M., Apte, R. N. and El-On, J. 2000. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro. Exp. Parasitol. 94:150.
23. El-On, J., Bazarsky, E. and Sneir, R. 2007. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Exp. Parasitol. 116:156.
24. Tupperwar, N., Vineeth, V., Rath, S. and Vaidya, T. 2008. Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagn. Microbiol. Infect. Dis. 61:23.
25. Song, X., Voronov, E., Dvorkin, T. et al. 2003. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol. 171:6448.
26. Huggett, J., Dheda, K., Bustin, S. and Zumla, A. 2005. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6:279.
27. Livak, K. J. and Schmittgen, T. D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402.
28. Aga, E., Katschinski, D. M., van Zandbergen, G. et al. 2002. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J. Immunol. 169:898.
29. Laskay, T., van Zandbergen, G. and Solbach, W. 2003. Neutrophil granulocytes-Trojan horses for Leishmania major and other intracellular microbes? Trends Microbiol. 11:210.
30. Bronte, V. 2009. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39:2670.
31. Kusmartsev, S. and Gabrilovich, D. I. 2006. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol. Immunother. 55:237.
32. Ostrand-Rosenberg, S. and Sinha, P. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499.
33. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791.
34. Delano, M. J., Scumpia, P. O., Weinstein, J. S. et al. 2007. MyD88dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463.
35. Gabrilovich, D. I. and Nagaraj, S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162.
36. Movahedi, K., Guilliams, M., Van den Bossche, J. et al. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111:4233.
37. Gallina, G., Dolcetti, L., Serafini, P. et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116:2777.
38. Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4:941.
39. Kusmartsev, S. and Gabrilovich, D. I. 2002. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 51:293.
40. 40Serafini,P.,Carbley,R.,Noonan,K.A.,Tan,G.,Bronte,V.and Borrello, I. 2004. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64:6337.
41. Serafini, P., De Santo, C., Marigo, I. et al. 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53:64.
42. Weiss, T., Vitacolonna, M. and Zoller, M. 2009. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction. J. Immunother. 32:552.
43. Brinster, C. and Shevach, E. M. 2008. Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3T cells. J. Leukoc. Biol. 84:480.
44. O'Sullivan, B. J., Thomas, H. E., Pai, S. et al. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176:7278.
45. Sacks, D. and Anderson, C. 2004. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201:225.
46. Johnson, L. M. and Scott, P. 2007. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major. J. Immunol. 178:7259.
47. Humphreys, N. E. and Grencis, R. K. 2009. IL-1-dependent, IL-1R1-independent resistance to gastrointestinal nematodes. Eur. J. Immunol. 39:1036.
48. Ben-Sasson, S. Z., Hu-Li, J., Quiel, J. et al. 2009. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl Acad. Sci. USA 106:7119.
49. Satoskar, A. R., Okano, M., Connaughton, S., Raisanen-Sokolwski, A., David, J. R. and Labow, M. 1998. Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol. 28:2066.
50. Cillari, E., Dieli, M., Maltese, E., Milano, S., Salerno, A. and Liew, F. Y. 1989. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J. Immunol. 143:2001.
51. Dumas, C., Muyombwe, A., Roy, G. et al. 2003. Recombinant Leishmania major secreting biologically active granulocytemacrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice. Infect. Immun. 71:6499.
52. Matte, C. and Olivier, M. 2002. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J. Infect. Dis. 185:673.
53. LeibundGut-Landmann, S., Gross, O., Robinson, M. J. et al. 2007. Sykand CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630.
54. Fossiez, F., Djossou, O., Chomarat, P. et al. 1996. T cell interleukin17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593.
55. Miyamoto, M., Prause, O., Sjostrand, M., Laan, M., Lotvall, J. and Linden, A. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170:4665.
56. Zelante, T., De Luca, A., Bonifazi, P. et al. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695.
57. Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y. 2003. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl Acad. Sci. USA 100:5986.
58. Dragon, S., Saffar, A. S., Shan, L. and Gounni, A. S. 2008. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol. Immunol. 45:160.
59. Stark, M. A., Huo, Y., Burcin, T. L., Morris, M. A., Olson, T. S. and Ley, K. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285.
60. Ribeiro-Gomes, F. L., Otero, A. C., Gomes, N. A. et al. 2004. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 172:4454.
61. Tacchini-Cottier, F., Zweifel, C., Belkaid, Y. et al. 2000. An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165:2628.
62. Lopez Kostka, S., Dinges, S., Griewank, K., Iwakura, Y., Udey, M. C. and von Stebut, E. 2009. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 182:3039.
63. Dinarello, C. A. 2005. Blocking IL-1 in systemic inflammation. J. Exp. Med. 201:1355.